BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21812721)

  • 1. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
    Devlin JM; Browning GF; Hartley CA; Gilkerson JR
    Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol.
    Devlin JM; Browning GF; Gilkerson JR; Fenton SP; Hartley CA
    Avian Pathol; 2008 Feb; 37(1):83-8. PubMed ID: 18202954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
    Devlin JM; Hartley CA; Gilkerson JR; Coppo MJ; Vaz P; Noormohammadi AH; Wells B; Rubite A; Dhand NK; Browning GF
    Vaccine; 2011 Aug; 29(34):5699-704. PubMed ID: 21689710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis.
    Kirkpatrick NC; Mahmoudian A; Colson CA; Devlin JM; Noormohammadi AH
    Avian Pathol; 2006 Dec; 35(6):449-53. PubMed ID: 17121733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A; Riblet SM; Zavala G; García M
    Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
    Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
    Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    Korsa MG; Devlin JM; Hartley CA; Browning GF; Coppo MJC; Quinteros JA; Loncoman CA; Onasanya AE; Thilakarathne D; Diaz-Méndez A
    PLoS One; 2018; 13(12):e0207611. PubMed ID: 30521554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
    Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
    Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.
    Lee SW; Devlin JM; Markham JF; Noormohammadi AH; Browning GF; Ficorilli NP; Hartley CA; Markham PF
    Vaccine; 2011 Dec; 29(52):9583-7. PubMed ID: 22044743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of route of vaccination on the prevention of infectious laryngotracheitis in commercial egg-laying chickens.
    Fulton RM; Schrader DL; Will M
    Avian Dis; 2000; 44(1):8-16. PubMed ID: 10737639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the replication and transmissibility of two infectious laryngotracheitis virus chicken embryo origin vaccines delivered via drinking water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(2):195-202. PubMed ID: 22515537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to infectious laryngotracheitis virus.
    Coppo MJ; Hartley CA; Devlin JM
    Dev Comp Immunol; 2013 Nov; 41(3):454-62. PubMed ID: 23567343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.